If we are serious about narrowing health gaps, then our environmental protections must be safeguarded against political ...
We must resist the temptation to reinterpret the Bayh-Dole Act even in an effort to improve the affordability of and access ...
Health Affairs' Rob Lott interviews Michael T. Osterholm, the director of the Center for Infectious Disease Research and ...
Valerie Lehman is an Assistant Research Director on the Health Care Transformation team at the Duke-Margolis Institute for Health Policy and manages the rapid lear ...
Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
Prior authorization is a barrier to accessing medications for opioid use disorder (MOUD). Although private insurance covered about one-third of patients with OUD in 2023, the understanding of prior ...
Under the Consolidated Appropriations Act, 2023, which required the provision of national twelve-month continuous Medicaid eligibility for children up to age nineteen, children’s Medicaid enrollment ...
US v. Skrmetti undermined constitutional guardrails that guarantee rigorous assessment of medical justifications for policies limiting the rights of transgender people and women, creating a need and ...
Ryan N. Hansen, PharmD, PhD, is professor and chair of the Department of Pharmacy, and faculty in the CHOICE Institute, School of Pharmacy, University of Washington, and chief technology officer at ...
There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback